animals develop significantly larger aneurysms than WT animals, correlating with higher pro-and active MMP-2 levels. These findings suggest that PAI-1 is protective for aneurysm formation in the elastase model of AAA and plays a role in the gender differences seen in AAA formation. gender differences; serine proteases; vascular surgery; abdominal aortic aneurysm; plasmin activator inhibitor-1 ABDOMINAL AORTIC ANEURYSM (AAA) is a common medical problem with an overall prevalence of ϳ9% in men and 2% in women (39) , with an increasing incidence in both genders with age. In the United States, ϳ35,000 to 40,000 patients undergo AAA repair each year (14) , while ϳ15,000 patients suffer rupture of their AAA. The molecular basis underlying this gender difference is unknown. However, if a specific molecular target could be identified, this could lead to an improvement in medical therapy for AAAs.
The serine proteases, including tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), and their main inhibitor, plasminogen activator inhibitor-1 (PAI-1), help to regulate the levels of plasmin in the blood. The serine proteases are typically thought of in the context of coagulation and thrombosis; however, they have also been demonstrated to also play a role in AAA formation through generation of plasmin. Plasmin can activate type I and type IV collagenase directly, as well as activate latent matrix metalloproteinase (MMP)-9 and -2, contributing to the breakdown of the aortic wall (18, 28, 44) . Significantly higher levels of tPA, along with a significant uPA-expressing mononuclear cell infiltration, have been identified in the walls of human aortic aneurysms compared with normal controls, with no specific PAI-1expres-sion seen in the aneurysm samples (34) . Another study demonstrated PAI-1 mRNA expression, along with uPA and tPA expression, in human AAA samples (38) . However, the areas expressing uPA and tPA were much more expansive, extending beyond the areas expressing PAI-1, indicating an imbalance between the plasminogen activators and inhibitor. Additionally, nearly 40-fold higher levels of plasmin have been detected in the aortic wall of patients with AAAs compared with normal controls (19) . Finally, localized overexpression of PAI-1 has been shown to prevent AAA development and rupture in animal models (1, 33) .
Given these findings, this study sought to determine if there was a difference in PAI-1 expression between males and females, hypothesizing that higher levels of PAI-1 in females compared with males may be protective for AAA formation and partially explain the gender difference observed in the incidence of human AAAs.
MATERIALS AND METHODS

Experimental protocol. Male and female wild-type (WT) and PAI-1
Ϫ/Ϫ animals 8 -12 wk of age were used for this study. Five animals from each of the four groups (WT male, WT female, PAI-1 Ϫ/Ϫ male, and PAI-1 Ϫ/Ϫ female) were killed before undergoing any intervention and used for baseline measurements, including mRNA analysis of the aortic tissue. Serum was also collected from each animal for baseline plasmin analysis by ELISA (Innovative Research, Novi, MI). A total of 8 WT males and 10 WT females were killed 24 h (day 1) following elastase perfusion and used to examine PAI-1 mRNA levels in the aortic tissue. A total of five WT males and five WT females were perfused with heat-inactivated elastase and killed at day 1 as controls, and PAI-1 mRNA levels were measured. mRNA was examined rather than protein given the early time point in experimental aneurysm formation.
Twelve animals from each of the WT male, WT female, PAI-1
male, and PAI-1 Ϫ/Ϫ female groups were harvested 14 days following elastase perfusion. All 12 animals in each group were used for phenotype analysis. Nine of the 12 animals were used for Western blot and zymography. Protein was examined given the late time point in aneurysm formation. The other three aortic samples were used for histology studies, including hematoxylin and eosin staining and immunohistochemical staining for PAI-1 and macrophages. Samples were randomly assigned to each group. Serum was collected from all animals at the time of harvest. For plasmin analysis at day 14, five samples from each of the three groups (WT male, WT female, and PAI-1 Ϫ/Ϫ female) were randomly chosen and compared with the five baseline samples from each group. All animal experiments were approved by the University of Michigan Universal Committee on the Use and Care of Animals (UCUCA no. 09679) or the University of Virginia Institutional Animal Care and Use Committee (IACUC no. 3848).
Aortic measurements. Change in aortic diameter was determined by taking photographs and measurements of the aorta of each animal using a video micrometer and NIS Elements software attached to the microscope (Nikon, Melville, NY) just before aortic perfusion and again just before death. Photos were taken just below the left renal vein (proximal), at the level of the iliolumbar vessels (mid), and just above the iliac bifurcation (distal) at both time points. The diameter at baseline before aortic perfusion was subtracted from the diameter at harvest at day 14 at each location. The largest difference (typically in the midaorta) was then used as the increase in aortic diameter for that animal, and the percent increase compared with baseline for that animal was calculated.
Rodent elastase perfusion. Mice were anesthetized with 2% isofluorane and 98% oxygen. A ventral vertical midline incision was made, and the abdominal aorta was exposed from the left renal vein to the iliac bifurcation. All side branches were cauterized or ligated with 10 -0 nylon suture (Surgical Specialties, Reading, PA) to ensure pressurization of the aorta. Baseline intraoperative photos and aortic measurements at the proximal, mid, and distal aorta were taken using a video micrometer and NIS Elements software attached to the microscope (Nikon). Temporary proximal and distal control of the aorta was obtained with 4 -0 silk suture (Ethicon, Somerville, NJ), and a 30-gauge needle was used to make an aortotomy just proximal to the iliac bifurcation. A custom polyethylene catheter (Braintree Scientific, Braintree, MA) was inserted through the aortotomy. A dilute porcine pancreatic elastase (0.4 units/ml; Sigma, St. Louis, MO) was infused to ensure a doubling in the aortic diameter for 5 min. The catheter was then removed, and the aortotomy was closed with a single 10 -0 nylon suture. Proximal and distal ligatures were then removed restoring blood flow to the lower extremities. The abdomen was closed in two layers with running 5-0 Vicryl suture (Ethicon), and the animal was allowed to emerge from anesthesia.
Rodent death. At time of death, animals were again anesthetized with 2% isofluorane and 98% oxygen, and the vertical ventral incision was reopened. The aorta was dissected free from the surrounding tissues, and repeat intraoperative photos and measurements were taken, again at the proximal, mid, and distal aorta while the animal was still alive. Blood was then collected from the inferior vena cava using a 25-gauge needle and 1-ml syringe (Becton-Dickinson, Franklin Lakes, NJ). The aorta was then removed from the level of the left renal vein to the iliac bifurcation and processed.
mRNA extraction and reverse transcription. Established techniques using TRIzol reagent (Invitrogen, Carlsbad, CA) were used to extract mRNA for real-time RT-PCR (10, 17) . In brief, explanted aortic tissue was added to 1.5 ml TRIzol reagent, and the tissue was homogenized. Chloroform (99%) was then added to the homogenized tissue, vortexed, and centrifuged. The clear supernatant was pipetted into Eppendorf tubes. RNA precipitation was performed with isopropanol (99%). The resulting solution was centrifuged. The supernatant was poured off, and the remaining mRNA pellet was washed by adding 70% ethanol in diethylpyrocarbonate (DEPC) water and centrifuged. The supernatant was then aspirated off, and the pellet was dried at room temperature. The pellet was then redissolved in DEPC water at 58°C. RNA concentration was then measured on the Nanodrop 1000 Spectrophotometer (ThermoScientific, Pittsburgh, PA). For producing cDNA, 5 g RNA were used in the reverse transcription reaction with standard reagents in a GeneAmp 2400 PCR System (Perkin ElmerApplied Biosystems, Norwalk, CT).
Quantitative real-time PCR. cDNA concentration was measured using the Nanodrop 1000 Spectrophotometer to calculate the amount needed to obtain 22 ng/ml for the RT-PCR reaction. Primers as well as the SYBR Green Master Mix used for qRT-PCR were obtained from SABiosciences (Qiagen, Frederick, MD). mRNA expression of PAI-1 (Serpine 1, catalog no. PPM03093B) was compared with that of ␤-actin, a housekeeping gene (catalog no. PPM02945A). The RotorGene 6000 Series Software 1.7 (Corbett Research; Qiagen) was used to amplify the target DNA and obtain the take-off values and melt curves for analysis. The following program was used on the Rotor Gene: 95°C for 10 min; 40 cycles of 95°C for 15 s and 60°C for 60 s.
Western blot. For Western blot analysis, the tissues were lysed by sonication and overnight incubation in ice-cold RIPA buffer (Sigma) containing protease and phosphatase inhibitors (Roche, Basel, Switzerland) (9, 10, 17) . Protein concentration in the lysate was determined with the BCA protein assay kit (Pierce, Rockford, IL). Equal amounts of protein were loaded into each well and resolved by SDS-PAGE with 10% gels (Novex; Invitrogen) and electroblotted on polyvinylidene membranes (Immobilon-P; Millipore, Billerica, MA) by semidry transfer blot (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. The membranes were incubated in StartBlock TBS (Pierce) for 1 h and then incubated with antibody for PAI-1 or uPA (Innovative Research, Novi, MI) in the StartBlock solution at 1:500 dilution overnight with gentle shaking. The membranes were washed in 25 mM Tris, 150 mM NaCl, and 0.1% Tween 20, pH 7.4 (TBST), for 1 h at room temperature and then incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody (1:2,000) (Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h and again washed in TBST. For normalization of proteins on the Western blots, the membranes were stripped and probed with anti-actin antibodies conjugated with HRP (Santa Cruz Biotechnology). The membranes were developed with the West-Pico ECL kit (Pierce).
Gelatin zymography for MMP-9 and -2. Gelatin substrate zymograms were run in precast 10% SDS-PAGE gels containing 1 mg/ml of gelatin (Invitrogen) (9, 10) . Equal amounts of protein were diluted into 2ϫ Tris-glycine SDS sample buffer and electrophoretically separated under nonreducing conditions. Proteins were renatured for 30 min in Renaturing Buffer (Invitrogen), and then the gels were incubated in the developing buffer (Invitrogen) for 30 min and again in the same buffer overnight at 37°C. The gel was stained in SimplyBlue SafeStain (Invitrogen) and the pro-MMP-9, pro-MMP-2, and active MMP-2 activity was observed by clear bands against the blue background.
Histology and immunohistochemical staining. Aortic tissue was fixed in 10% buffered formaldehyde for 2 h, transferred to 70% ethanol, and subsequently embedded in paraffin. Sections were then stained with hematoxylin and eosin, for PAI-1 or for macrophages. For PAI-1 staining, aortic sections were deparaffinized in xylene and rehydrated in graded alcohols. Heat-induced antigen retrieval using 10 mM sodium citrate, pH 6.0, was performed in a microwave. Sections were subsequently incubated with 3% hydrogen peroxide in methanol to block endogenous peroxidase activity, followed by a blocking buffer to prevent nonspecific binding. Sections were then incubated with the primary antibody overnight at a dilution of 1:100 in blocking solution and stained according to the instructions in the Vectastain ABC Elite and Novared Kits (Vector Laboratories, Burlingame, CA). Immunohistochemical staining of mouse migratory macrophage was performed as described in previous methods (21, 45, 46) . Rat antimouse Mac-2 (Accurate Chemistry, Westbury, NY) was used as primary antibody (1:5,000 dilution). Alkaline phosphatase-conjugated anti-rat IgG (Sigma) was employed as a secondary antibody. The signals were detected using Fast-Red (Sigma). For negative controls, we used purified normal rat IgG (eBioscience, San Diego, CA). For immunofluorescence staining, the cell nucleus was stained with 4,6-diamidine-2-phenylindole dihydrochloride (DAPI; Roche Diagnostics, Mannheim, Germany). After being stained, the sections were dehydrated, and pictures were taken with a Nikon microscope equipped with a charge-coupled device camera.
Densitometric analysis. Quantification of macrophage positive immunostaining signals was performed using Image-J software (21, 45, 46) . Briefly, four photos were taken from each group with an Olympus BX51 microscope equipped with an Olympus DP70 digital camera (Minneapolis, MN). An appropriate color threshold (RGB) was chosen (hue: 5-30, saturation: 200 -255, brightness: 100 -227) to include the positive staining of signal. The integrated optical density value of positive staining area of each section was randomly selected and measured. Fourteen randomly selected ϫ20 fields per aneurysm section were assessed for the density of staining. The positive signal in aneurysm for each group was semiquantified using a Macintosh computer and the public domain software, Image J (U.S. National Institutes of Health, available at http://rsb.info.nih.gov/nih-image). The integrated density of the signal was acquired for statistics analysis.
Statistical analysis. Various data points were collected and entered into a database (Microsoft Excel 2007; Microsoft, Redmond, WA).
Comparison statistics between groups were determined using a Student's t-test in PRISM software (GraphPad Software, La Jolla, CA). Data are presented as means Ϯ SD along with significance values.
RESULTS
Changes in aortic diameter. There was not a significant difference in aortic diameter between male and female WT mice, male and female PAI-1 Ϫ/Ϫ , male WT and PAI-1
mice, or female WT and PAI-1 Ϫ/Ϫ mice at baseline (data not shown). An aneurysm was defined as a Ͼ50% increase compared with baseline. At day 14, the endpoint of this model, WT males experienced an increase in aortic diameter of 80 Ϯ 27% compared with baseline, whereas females only had an increase of 32 Ϯ 13% (P Ͻ 0.001) (Fig. 1A) . Ninety percent of the males formed an aneurysm compared with only 7% of females (one animal) at this time point. PAI-1 Ϫ/Ϫ males and females perfused with elastase formed large aneurysms, with an average increase in aortic diameter of 204 Ϯ 28% in the males and 161 Ϯ 13% for the females at day 14 (Fig. 1A) . All of these animals formed AAAs. The PAI-1 Ϫ/Ϫ males formed significantly larger aneurysms than the WT males (P Ͻ 0.001). The same was true for the females (P Ͻ 0.001). There was not a significant difference in aortic diameter at day 14 between the PAI-1 Ϫ/Ϫ males and females (P ϭ 0.18). PAI-1 mRNA expression in WT mice. There was no significant difference in PAI-1 mRNA expression between WT males and females at baseline (data not shown). At day 1, an early time point in this model, WT females had 35% higher PAI-1 mRNA expression compared with WT males (P ϭ 0.026), demonstrating that differences in PAI-1 begin early in AAA formation (Fig. 1B) . Infusion of heat-inactivated elastase did not lead to a significant difference in PAI-1 expression at day 1 (data not shown).
PAI-1 protein levels in WT mice. On day 14, WT females had 61% higher PAI-1 protein levels by Western blot compared with WT males (P ϭ 0.01), demonstrating that differences in PAI-1 persist even late in aneurysm formation (Fig.  1C) . Immunohistochemical staining for PAI-1 in WT male and female samples confirmed this observation, with increased PAI-1 staining in the female compared with the male (Fig. 1D) .
uPA protein levels in WT and PAI-1
Ϫ/Ϫ mice. At baseline, the PAI-1 Ϫ/Ϫ male had significantly more uPA protein in the aortic tissue compared with the WT male (P Ͻ 0.001), as well as the female PAI-1 Ϫ/Ϫ mice (P ϭ 0.021) (Fig. 2 ). There were no differences in uPA protein between the WT male and WT female or between the WT female and PAI-1 Ϫ/Ϫ female at baseline. These same differences persisted at day 14. The PAI-1 Ϫ/Ϫ male had significantly more uPA than the WT male (P Ͻ 0.001) and the PAI-1 Ϫ/Ϫ female (P Ͻ 0.001), with no difference between the WT male and WT female or between the WT female and PAI-1 Ϫ/Ϫ female (Fig. 2) . These differences in tissue levels of uPA did not correspond to a difference in serum uPA protein levels (data not shown).
MMP activity. Gelatin zymography, performed on aortic tissue at day 14 to assess for MMP-9 and -2 activity, revealed significantly lower levels of pro-MMP-9, pro-MMP-2, and active MMP-2 (P ϭ 0.034, P Ͻ 0.001, and P ϭ 0.011, respectively) in the WT female compared with WT male, consistent with their respective aneurysm phenotypes (Fig. 3 ). There were no differences in pro-MMP-9 activity seen between the PAI-1 Ϫ/Ϫ animals and their WT counterparts. However, the PAI-1 Ϫ/Ϫ males had significantly higher levels of pro-MMP-2 (P ϭ 0.046) and active MMP-2 (P ϭ 0.003) than the WT males (Fig. 3) . Similarly, the PAI-1 Ϫ/Ϫ females had higher levels of pro-MMP-2 (P Ͻ 0.001) and active MMP-2 (P ϭ 0.012) than the WT females (Fig. 3 ). There were no differences between the PAI-1 Ϫ/Ϫ males and females in pro-MMP-9, pro-MMP-2, or active MMP-2.
Macrophages and inflammation. Representative hematoxylin and eosin staining of aneurysm samples at day 14 demonstrates the aortic size difference between the WT female that did not form an aneurysm and the WT male, PAI-1 Ϫ/Ϫ male, and PAI-1 Ϫ/Ϫ female, all of which did form aneurysms (Fig. 4 ). An intense inflammatory reaction can be seen in the animals that formed AAAs. Immunohistochemical staining for macrophages using a MAC-2 antibody stain demonstrates no macrophages in the WT female compared with numerous macrophages in the WT male (Fig. 5) . The PAI-1 Ϫ/Ϫ male and female both had diffuse macrophage infiltration, with significantly more macrophages in the PAI-1 Ϫ/Ϫ male compared with the PAI-1 Ϫ/Ϫ female (P ϭ 0.005) (Fig. 5) . Serum plasmin. There were no differences in serum plasmin levels at baseline between the WT males, WT females, and PAI-1 Ϫ/Ϫ females (Fig. 6) . However, at day 14, the PAI-1 Ϫ/Ϫ females had significantly higher serum plasmin levels compared with the WT females (P ϭ 0.003) (Fig. 6) , consistent with them lacking PAI-1 and having unopposed tPA and uPA activity. The plasmin enzyme-linked immunosorbent assay kit is not currently commercially available, and the PAI-1 Ϫ/Ϫ male serum was unable to be studied.
DISCUSSION
This study demonstrates that there are differences in experimental AAA formation between WT male and female mice using the elastase perfusion model that parallel the differences seen in humans, with females being protected from aneurysm formation. Correlated with this phenotypic difference were lower pro-MMP-9, pro-MMP-2, and active MMP-2 levels, all known to be important in AAA formation (32, 37), along with higher PAI-1 levels in the female compared with the male mice. Additionally, the females had less macrophage infiltration than males, again correlating with decreased aneurysm formation.
The protective nature of PAI-1 for AAA became clear when male and female PAI-1 Ϫ/Ϫ mice were perfused with elastase and formed very large aneurysms compared with their WT counterparts. There was a trend toward significantly larger aneurysms in PAI-1 Ϫ/Ϫ males, which demonstrated higher levels of uPA in the aortic tissue compared with the PAI-1 Ϫ/Ϫ females. However, all of the differences in aneurysm phenotype cannot be explained by differences in uPA, since there were significant differences in aortic diameter between the WT male and WT female, as well as between the WT female and PAI-1 Ϫ/Ϫ female, despite there not being any significant differences between these groups in tissue levels of uPA. Additionally, these differences in uPA at day 14 parallel the differences that were present at baseline.
The large AAAs in the PAI-1 Ϫ/Ϫ animals are unique and correlated with higher levels of pro and active MMP2, as well as with increased macrophage infiltration compared with the gender-matched WT mice. Finally, the PAI-1 Ϫ/Ϫ females had higher serum plasmin levels compared with the WT females, as would be expected with virtually unopposed activation of the plasminogen/plasmin system.
Regulation of PAI-1 occurs mainly at the transcription level, and inflammatory cytokines, such as interleukin-6, tissue necrosis factor, and transforming growth factor-␤, in addition to insulin, insulin-like growth factor, angiotensin II, and aldosterone, can lead to upregulation of PAI-1 gene expression (3, 16). PAI-1 is synthesized in several cell types, including endothelial cells, megakaryocytes, smooth muscle cells, fibroblasts, macrophages, endometrium, cardiac myocytes, hepatocytes, and adipocytes (5, 16) .
The female sex steroids estrogen and progesterone have also been shown to play a role in regulation of PAI-1 in several cell types. When human female aortic endothelial cells were exposed to physiological levels of 17␤-estradiol, there was a 2.3-fold increase in PAI-1 mRNA seen (42) . A similar effect was seen in cultured bovine aortic endothelial cells. When 17␤-estradiol was added, a statistically significant twofold increase in secreted PAI-1 was detected (41) . A nonsignificant increase was also seen in response to progesterone. In the uterine endometrial cancer cell line Ishikawa, both estrogen and progesterone led to increases in PAI-1 mRNA production, with a synergistic effect seen with coadministration of estrogen and progesterone (13) .
However, in a breast cancer cell line, uPA, tPA, and PAI-1 protein were all downregulated in a dose-dependent manner by exposure of the cells to estradiol (25) . Additionally, when the human PAI-1 promoter was transfected into bovine aortic endothelial cells, activation of estrogen receptor-␣ increased the activity of the promoter in an estrogen-dependent fashion, whereas estrogen receptor-␤ suppressed the activity of the Fig. 4 . Representative hematoxylin-and eosin-stained sections for each of the four groups studied at low (ϫ4) and high (ϫ20) magnification. Arrows demonstrate white blood cell infiltration in the aortic wall. Fig. 3 . Changes in matrix metalloproteinase (MMP) levels. Representative lanes from zymograms for pro-MMP-9, pro-MMP-2, and active MMP-2 for each of the four groups studied are shown. Graphs represent the average relative intensity of the various MMP bands for each group. PAI-1 promoter in an estrogen-independent fashion (40) . These studies highlight the highly specific and sometimes opposite effects of estrogen on regulation of the serine proteases depending on the specific tissue type and receptor present.
Additionally, genetic polymorphisms in the PAI-1 gene promoter can lead to different PAI-1 concentrations. Individuals who are 4G/4G homozygotes have the highest PAI-1 activity, those who are 5G/5G the lowest, and intermediate activity in 4G/5G heterozygotes (3, 35) . In a study of 190 patients with AAAs, 39 of which had a strong family history of AAA, and 163 controls, investigators found that the 4G allele frequency was significantly lower, and consequently the 5G allele higher, in the patients who had a family history of AAAs compared with both the nonfamilial AAA patients and controls (35) . This suggests that lower levels of PAI-1 secondary to the 4G allele have been selected in those patients with familial AAAs and that PAI-1 may indeed be protective for AAA formation. In another study of 455 patients with AAAs between 4.0 and 5.5 cm, patients with the 5G/5G polymorphism had increased aneurysm growth rate that showed a trend toward significance (P ϭ 0.06) and significantly lower plasma PAI-1concentrations compared with the 4G/5G and 4G/4G patients (11) .
A different study examining patients with small AAAs analyzed serum levels of uPA, tPA, and PAI-1 among other markers regularly at the time of surveillance ultrasound measurement of the aorta. Of the serine proteases, only tPA was found to have a positive correlation with aneurysm growth rate, indicating that aortic matrix degradation and aneurysm expansion may be partially caused by plasmin generated as a result of increases in tPA (26) . Another population-based study looked at tPA levels and the tPA/PAI-1 complex in 42 patients with AAAs compared with 100 normal controls. This study also demonstrated that tPA levels were significantly higher in the patients with AAAs compared with controls (43). However, there was not a difference in the tPA/PAI-1 complex between the groups, indicating that an excess of tPA seemed to be present in the patients with AAAs compared with controls.
In a study examining human aortic vascular smooth muscle cells (VSMC) obtained from patients undergoing AAA repair and organ donors without AAA, both tPA and uPA were found in the medium of the cells from patients with AAA, but both were undetectable in the normal cells (27) . tPA and uPA levels were also higher in the cell extracts from the AAA cells compared with controls. However, there was no difference in PAI-1 between the groups in the medium or the cellular extract, indicating an abundance of plasminogen activators in the patients who had developed AAAs.
Interestingly, in VSMCs harvested from rat carotid arteries, tPA and uPA have been shown to induce PAI-1 secretion (22) . This upregulation of PAI-1 has been shown to be mediated by the protein kinase C and mitogen-activated protein kinase pathways and inhibited by activation of the protein kinase A pathway (23) . Thus, it is the balance of these factors that helps to determine the plasminogen activator/inhibitor balance.
Other studies have looked at the connection between the serine proteases and AAA formation in animal models, mostly with a focus on uPA and tPA. In the angiotensin II model of AAA formation, uPA has been shown to play a critical role in AAA development, with only 20% of apolipoprotein E (ApoE)
Ϫ/Ϫ mice developing AAAs compared with 90% in the ApoE Ϫ/Ϫ /uPA ϩ/ϩ mice, without any differences in diameter in the nonaneurysmal portion of the aorta (7). When WT mice were examined using the same model, uPA was localized in mononuclear cells infiltrating the aneurysmal portion of the aorta. PAI-1 was also seen in the mononuclear cells, but with weaker signal compared with uPA. In another study using the same model but in female mice, investigators found that ApoE Ϫ/Ϫ /uPA Ϫ/Ϫ mice were protected against destruction of the media layer of the aorta and aneurysm formation, whereas ApoE Ϫ/Ϫ /tPA Ϫ/Ϫ mice were not protected (4) . With the use of in vitro studies, these investigators demonstrated that plasmin generated from uPA was able to activate pro-MMP-3, pro-MMP-9, pro-MMP-12, and pro-MMP-13, helping to strengthen the link between the serine proteases and MMP activation. This study did not examine the role of PAI-1. Finally, another in vitro study confirmed that pro-MMP-9 was converted to the active form by the addition of plasminogen in a dose-dependent manner (2) . Moreover, while the addition of plasminogen did not convert pro-MMP-2 to active MMP-2, conversion of the 64-kDa MMP-2 intermediate to active MMP-2 was mediated by plasminogen.
In addition to decreasing the amount of MMP activation and collagen breakdown by decreasing plasmin levels, increased levels of PAI-1 can also modulate plasminogen-mediated apoptosis of VSMC (20) . This is thought to be mediated through direct inhibition of caspase-3 by PAI-1 (6, 20) . Similar results were seen using aortic VSMC from PAI-1 Ϫ/Ϫ mice. Morphological changes consistent with apoptosis occurred earlier, and the apoptotic index was higher following the addition of plasminogen to the PAI-1 Ϫ/Ϫ cells compared with aortic VSMC from tPA Ϫ/Ϫ , uPA Ϫ/Ϫ , and WT mice (36) . The apoptotic index was the same for all four groups without the addition of plasminogen. These results demonstrate that plasminogen does indeed play a role in VSMC apoptosis and that PAI-1 helps to keep this process in check. Therefore, inhibition of apoptosis is likely another mechanism whereby PAI-1 mediates preservation of the aortic wall and protects against AAA formation.
In our study, we saw drastic differences in the amount of inflammation, and particularly macrophage infiltration, between the animals that formed aneurysms (WT males, PAI-1 Ϫ/Ϫ males, and PAI-1 Ϫ/Ϫ females) and those that did not (WT females). Differences in plasmin may account for these differences as well. In a mouse model of inflammation, plasminogen Ϫ/Ϫ mice had significantly diminished monocyte recruitment to the site of inflammation compared with WT mice, despite similar levels of monocytes in the blood and equivalent phagocytic activity (31) . In a similar study, macrophage migration was demonstrated to be reduced in plasminogen Ϫ/Ϫ mice, and macrophage recruitment was found to be significantly increased in PAI-1 Ϫ/Ϫ mice, similar to our results (15) . These investigators also demonstrated that plasminogen was able to activate MMP-9, which was found in the macrophages, and that this MMP-9 activation was necessary for macrophage migration through the extracellular matrix. Finally, they demonstrated that plasminogen Ϫ/Ϫ mice did not form AAAs, had 50% less macrophage infiltration compared with the WT, and an 80% reduction in both MMP-9 and -2, demonstrating the critical role of plasmin in MMP activation and aneurysm development (15) . Other investigators have demonstrated that this effect is likely in part mediated via the S100A10 cell surface receptor (29) .
Aortic aneurysm disease is unique from other vascular diseases in the fact that diabetes has actually been shown to be a protective factor rather than contributing to the progression of the disease (24) . One possible explanation for this observation could be related to increases in PAI-1. Diabetic patients have been shown to have higher serum levels of PAI-1 (12, 30) , and immunostaining of internal mammary artery samples from diabetic and nondiabetic patients undergoing coronary artery bypass surgery revealed nearly two times as much PAI-1 staining in the vessel wall of diabetics compared with controls (30) . The PAI-1 immunostaining was located in the intima and media of the vessel wall. In a rodent model of AAA formation, diabetic mice had decreased aortic diameter, increased plasma PAI-1 levels, and decreased plasmin levels compared with nondiabetic animals undergoing the same procedure (8) . Immunostaining confirmed increased intensity of PAI-1 in the diabetic mice, again concentrated in the intima and media of the aorta. Additionally, the diabetic mice had decreased macrophage influx and MMP-9 levels, corresponding to their reduced aneurysm formation.
In conclusion, we have demonstrated that WT female mice have higher levels of PAI-1 and are protected from AAA formation compared with WT males. Additionally, both male and female PAI-1 Ϫ/Ϫ mice were not protected from AAA formation and formed significantly larger aneurysms than their WT counterparts. These larger aneurysms were associated with increases in pro and active MMP-2 and increased macrophage influx, both factors known to be important in AAA formation. While previous studies have demonstrated that local overexpression of PAI-1 using molecular biology techniques in rodent models prevents aneurysm formation (1, 33) , and that patients with higher PAI-1 levels are protected from AAA formation, to our knowledge this is the first report of differences in PAI-1 between genders during the process of AAA formation in a rodent model. This difference in PAI-1 between males and females may indeed partially explain the gender difference seen in the incidence of AAAs in humans.
